LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Lapatinib | 10 | uM | LJP6 | 72 | hr | 929 | 2495 | 3216 | 0.7759 | 0.7352 |
Hs 578T | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 929 | 2228 | 3216 | 0.6926 | 0.6286 |
Hs 578T | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 929 | 2222 | 3216 | 0.6905 | 0.6252 |
Hs 578T | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 929 | 2179 | 3216 | 0.6773 | 0.6083 |
Hs 578T | Sirolimus | 1.11 | uM | LJP6 | 72 | hr | 929 | 2298 | 3216 | 0.7143 | 0.6570 |
Hs 578T | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 929 | 2245 | 3216 | 0.6980 | 0.6363 |
Hs 578T | Sirolimus | 10 | uM | LJP6 | 72 | hr | 929 | 2276 | 3216 | 0.7077 | 0.6489 |
Hs 578T | ZSTK474 | 0.04 | uM | LJP6 | 72 | hr | 929 | 2659 | 3216 | 0.8269 | 0.7986 |
Hs 578T | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 929 | 2261 | 3216 | 0.7031 | 0.6429 |
Hs 578T | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 929 | 1832 | 3216 | 0.5695 | 0.4605 |
Hs 578T | ZSTK474 | 1.11 | uM | LJP6 | 72 | hr | 929 | 1575 | 3216 | 0.4898 | 0.3426 |
Hs 578T | ZSTK474 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1457 | 3216 | 0.4530 | 0.2853 |
Hs 578T | ZSTK474 | 10 | uM | LJP6 | 72 | hr | 929 | 1256 | 3216 | 0.3906 | 0.1829 |
Hs 578T | BX-912 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3149 | 3237 | 0.9729 | 0.9697 |
Hs 578T | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 929 | 3047 | 3237 | 0.9415 | 0.9343 |
Hs 578T | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 929 | 2804 | 3237 | 0.8665 | 0.8470 |
Hs 578T | BX-912 | 1.11 | uM | LJP5 | 72 | hr | 929 | 1708 | 3237 | 0.5274 | 0.4014 |
Hs 578T | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 929 | 1348 | 3237 | 0.4166 | 0.2297 |
Hs 578T | BX-912 | 10 | uM | LJP5 | 72 | hr | 929 | 934 | 3237 | 0.2887 | 0.0032 |
Hs 578T | Selumetinib | 0.04 | uM | LJP6 | 72 | hr | 929 | 2018 | 3216 | 0.6274 | 0.5417 |
Hs 578T | Selumetinib | 0.12 | uM | LJP6 | 72 | hr | 929 | 1796 | 3216 | 0.5583 | 0.4445 |
Hs 578T | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 929 | 1748 | 3216 | 0.5434 | 0.4225 |
Hs 578T | Selumetinib | 1.11 | uM | LJP6 | 72 | hr | 929 | 1707 | 3216 | 0.5307 | 0.4042 |
Hs 578T | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 1651 | 3216 | 0.5133 | 0.3781 |
Hs 578T | Selumetinib | 10 | uM | LJP6 | 72 | hr | 929 | 1501 | 3216 | 0.4666 | 0.3066 |